drugset / Trial / NCT05817643
Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers
Phase 1
Unknown
12 enrolled
Allyx Therapeutics
Michael J. Fox Foundation for Parkinson's Research · collab
RandomizedCrossoverOpen-labelTreatment
Summary
This project is developing a novel disease-modifying compound for Alzheimer's disease (AD).
Timeline
- Start
- 2023-01-10
- Primary completion
- 2023-02-27
- Completion
- 2024-11-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BMS-984923 | Small molecule | — | Oral |